Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction
(2017) In Journal of Cardiovascular Magnetic Resonance 19(1).- Abstract
Background: Accurate assessment of myocardium at risk (MaR) after acute myocardial infarction (AMI) is necessary when assessing myocardial salvage. Contrast-enhanced steady-state free precession (CE-SSFP) is a recently developed cardiovascular magnetic resonance (CMR) method for assessment of MaR up to 1 week after AMI. Our aim was to validate CE-SSFP for determination of MaR in an experimental porcine model using myocardial perfusion single-photon emission computed tomography (MPS) as a reference standard and to test the stability of MaR-quantification over time after injecting gadolinium-based contrast. Methods: Eleven pigs were subjected to either 35 or 40 min occlusion of the left anterior descending artery followed by six hours of... (More)
Background: Accurate assessment of myocardium at risk (MaR) after acute myocardial infarction (AMI) is necessary when assessing myocardial salvage. Contrast-enhanced steady-state free precession (CE-SSFP) is a recently developed cardiovascular magnetic resonance (CMR) method for assessment of MaR up to 1 week after AMI. Our aim was to validate CE-SSFP for determination of MaR in an experimental porcine model using myocardial perfusion single-photon emission computed tomography (MPS) as a reference standard and to test the stability of MaR-quantification over time after injecting gadolinium-based contrast. Methods: Eleven pigs were subjected to either 35 or 40 min occlusion of the left anterior descending artery followed by six hours of reperfusion. A technetium-based perfusion tracer was administered intravenously ten minutes before reperfusion. In-vivo and ex-vivo CE-SSFP CMR was performed followed by ex-vivo MPS imaging. MaR was expressed as % of left ventricular mass (LVM). Results: There was good agreement between MaR by ex-vivo CMR and MaR by MPS (bias: 1 ± 3% LVM, r 2 = 0.92, p < 0.001), between ex-vivo and in-vivo CMR (bias 0 ± 2% LVM, r 2 = 0.94, p < 0.001) and between in-vivo CMR and MPS (bias -2 ± 3% LVM, r 2 = 0.87, p < 0.001. No change in MaR was seen over the first 30 min after contrast injection (p = 0.95). Conclusions: Contrast-enhanced SSFP cine CMR can be used to measure MaR, both in vivo and ex vivo, in a porcine model with good accuracy and precision over the first 30 min after contrast injection. This offers the option to use the less complex ex-vivo imaging when determining myocardial salvage in experimental studies.
(Less)
- author
- Nordlund, David LU ; Kanski, Mikael LU ; Jablonowski, Robert LU ; Koul, Sasha LU ; Erlinge, David LU ; Carlsson, Marcus LU ; Engblom, Henrik LU ; Aletras, Anthony H. LU and Arheden, Håkan LU
- organization
- publishing date
- 2017-01-30
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- AAR, Area at risk, CE-SSFP, Myocardium at risk
- in
- Journal of Cardiovascular Magnetic Resonance
- volume
- 19
- issue
- 1
- article number
- 12
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:28132648
- wos:000392985000001
- scopus:85010953286
- ISSN
- 1097-6647
- DOI
- 10.1186/s12968-017-0325-y
- language
- English
- LU publication?
- yes
- id
- 5b8d9e3c-11ac-4b43-8595-d60c3d4e1198
- date added to LUP
- 2017-02-14 13:22:51
- date last changed
- 2025-01-07 06:55:54
@article{5b8d9e3c-11ac-4b43-8595-d60c3d4e1198, abstract = {{<p>Background: Accurate assessment of myocardium at risk (MaR) after acute myocardial infarction (AMI) is necessary when assessing myocardial salvage. Contrast-enhanced steady-state free precession (CE-SSFP) is a recently developed cardiovascular magnetic resonance (CMR) method for assessment of MaR up to 1 week after AMI. Our aim was to validate CE-SSFP for determination of MaR in an experimental porcine model using myocardial perfusion single-photon emission computed tomography (MPS) as a reference standard and to test the stability of MaR-quantification over time after injecting gadolinium-based contrast. Methods: Eleven pigs were subjected to either 35 or 40 min occlusion of the left anterior descending artery followed by six hours of reperfusion. A technetium-based perfusion tracer was administered intravenously ten minutes before reperfusion. In-vivo and ex-vivo CE-SSFP CMR was performed followed by ex-vivo MPS imaging. MaR was expressed as % of left ventricular mass (LVM). Results: There was good agreement between MaR by ex-vivo CMR and MaR by MPS (bias: 1 ± 3% LVM, r <sup>2</sup> = 0.92, p < 0.001), between ex-vivo and in-vivo CMR (bias 0 ± 2% LVM, r <sup>2</sup> = 0.94, p < 0.001) and between in-vivo CMR and MPS (bias -2 ± 3% LVM, r <sup>2</sup> = 0.87, p < 0.001. No change in MaR was seen over the first 30 min after contrast injection (p = 0.95). Conclusions: Contrast-enhanced SSFP cine CMR can be used to measure MaR, both in vivo and ex vivo, in a porcine model with good accuracy and precision over the first 30 min after contrast injection. This offers the option to use the less complex ex-vivo imaging when determining myocardial salvage in experimental studies.</p>}}, author = {{Nordlund, David and Kanski, Mikael and Jablonowski, Robert and Koul, Sasha and Erlinge, David and Carlsson, Marcus and Engblom, Henrik and Aletras, Anthony H. and Arheden, Håkan}}, issn = {{1097-6647}}, keywords = {{AAR; Area at risk; CE-SSFP; Myocardium at risk}}, language = {{eng}}, month = {{01}}, number = {{1}}, publisher = {{BioMed Central (BMC)}}, series = {{Journal of Cardiovascular Magnetic Resonance}}, title = {{Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction}}, url = {{http://dx.doi.org/10.1186/s12968-017-0325-y}}, doi = {{10.1186/s12968-017-0325-y}}, volume = {{19}}, year = {{2017}}, }